In vitro antioxidant properties of potential biotransformaton products of salicylate, sulphasalazine and aminodypyrine

Journal of Free Radicals in Biology & Medicine - Tập 1 - Trang 273-280 - 1985
W.H. Betts1, M.W. Whitehouse2, L.G. Cleland1, B. Vernon-Roberts2
1TQEH-RAH Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, South Australia, 5011, Australia
2Department of Pathology, University of Adelaide, Adelaide, South Australia, 5000, Australia

Tài liệu tham khảo

Leymeyer, 1978, Effect of anti-inflammatory drugs and agents that elevate intracellular cylcic AMP on the release of toxic oxygen metabolites by phagocytes: studies in a model of tissue bond IgG, Clin. Immunol. Immunopathol., 9, 482, 10.1016/0090-1229(78)90144-7 Simchoswitz, 1979, Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs, Arthritis Rheum., 22, 755, 10.1002/art.1780220711 Herzer, 1980, Inhibition of glanulocyte function by prednisone and non-steroid anti-inflammatory drugs: quantitative evaluation with NBT test and its correlation with phagocytosis, Immunobiol., 157, 78, 10.1016/S0171-2985(80)80065-9 Van Dyke, 1979, A new screening system for non-steroidal antiinflammatory drugs based upon inhibition of chemiluminescence produced from human cells (granulocytes), Clin. Chem., 25, 1655, 10.1093/clinchem/25.9.1655 Pekoe, 1982, Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescen form myeloperoxidase reaction, Agents Actions, 12, 371, 10.1007/BF01965406 Betts, 1982, Effect of metal chelators and antinflammatory durgs on the degradation of hyaluronic acid, Arthritis Rheum., 25, 1469, 10.1002/art.1780251213 Cleland, 1983, Role of iron and influence of anti-inflammatory on oxygen derived free radical production and reactivity, J. Rheumatol., 9, 885 Whitehouse, 1976, Alternatives to aspirin derived from biological sources, Agents Actions Suppl., 43, 10.1007/BF01972185 Sagone, 1980, A new method for the detection of hydroxyl radical production by phagocytic cells, Biochim. Biophys. Acta, 628, 90, 10.1016/0304-4165(80)90354-2 Dakin, 1941, Catechol Organic Syntheses Coll., Vol. 1, 149 Booth, 1938, The specificity of xanthine oxidase, Biochem. J., 32, 495 W.H. Betts. Detecting oxy radicals using chemiluminescence In: Handbook of Methods for Oxy Radical Research (R. Greenwald,ed.), CRC Press, Boca Raton, Florida (in press) Halliwell, 1978, Superoxide-dependent formation of hydroxyl radicals in the presence of ironchelates. Is it a mechanism for hydroxyl radical production in biochemical systems?, FEBS Lett., 92, 321, 10.1016/0014-5793(78)80779-0 Williams, 1959 Acheson, 1960, The free radical nature of aromatic hydroxylation effected by oxygen, ascorbic acid and ferrous ion, Biochim. Biophys. Acta, 42, 49, 10.1016/0006-3002(60)90751-4 Boreham, 1969, The kinetics of elimination of salicylic acid and the formation of genetics acid, Br. J. Pharmacol., 37, 294, 10.1111/j.1476-5381.1969.tb09546.x Cleland, 1985, Plasma and synovial fluid gentisate in patients receiving salicylate therapy, J. Rheumatol., 12, 136 Peppercorn, 1976, The role of intestinal bacteria in the metabolism of salicylazosulfapyridine, J. Pharmac. Exp. Therap., 181, 555 Swartz, 1948, Treatment of rheumatoid polyarthritis with acid azo compounds, Rheumatology, 4, 56 McConkey, 1980, Sulphasalazine in rheumatoid arthritis, Brit. Med. J., 1, 442, 10.1136/bmj.280.6212.442 Bird, 1982, A biochemical assessment of sulphasalazine in rheumatoid arthritis, J. Rheumatol., 9, 36 Carrol, 1983, A comparative study of sulphasalazine and penicillamine in the treatment of RA, Aust. Rheum. Assoc. Mtg. Perth abstr Sinclair, 1948, Salzopyrin in the treatment of rheumatoid arthritis, Ann. Rheum. Dis., 8, 226, 10.1136/ard.8.3.226 Kuzell, 1950, Salicylazopyridine in rheumatoid arthritis and experimental polyarthritis, Calif. Med., 73, 476 Brodie, 1950, The fate of aminopyrine (pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material, J. Pharmacol. exp. Therap., 99, 171 Goromaru, 1976, Metabolism and excretion of aminopyrine in man, Chem. Pharmacol. Bull., 24, 1376, 10.1248/cpb.24.1376 Beyer, 1981, Metabolism of pyralazone derivatives, Dtsch. ApothZtg., 121, 1868 Beyer, 1981, Chem. Abstr., 95, 2,4592 Kuehl, 1980, Prostaglandins, arachidonic acid and inflammation, Science, 210, 978, 10.1126/science.6254151 Koshihara, 1984, Caffeic acid is a selective inhibitor of leukotriene synthesis, Biochim. Biophys. Acta, 792, 92, 10.1016/0005-2760(84)90287-X Chang, 1984, Differential effects of putative lipoxygenase inhibitors on archidonic aicd metabolism of cell-free and intact cell preparations, Inflammations, 8, 143, 10.1007/BF00916090 Yamamoto, 1984, Arachidonate 5-lipoxygenase and its new inhibitors, J. Allergy Clin. Immunology, 74, 349, 10.1016/0091-6749(84)90128-3 Whitehouds, 1964, Uncoupling of oxidative phophorylation in a connective tissue (cartilage) and liver mitochondria by salicylate analogues: relationship of structure to activity, Biochem. Pharmacol., 13, 319 Hutt, 1982, The metabolism of [carboxyl-14C] aspirin in man, Xenobiotica, 12, 601, 10.3109/00498258209042038 Cohen, 1964, Generation of hydrogen peroxide in erythrocytes by hemolytic agents, Biochemistry, 3, 895, 10.1021/bi00895a006